It was recently reported that the serum levels of SNHG5 were up-regulated in patients with malignant melanoma, and that SNHG5 may function in melanomagenesis or melanoma metastasis.[16] Further studies are needed to understand the underlying mechanisms of nucleotide substitutions on cancers and their subtypes. This evidence concerns the gene SNHG5 and melanoma.